Skip to content

Dr. Sandra Verelst

Active
Private limited companyfounded 2023active for 3 yearsMolenstraat 156, 2560 Nijlen, BelgiumKBO/BCE: BE 0804.259.068
Summary

Dr. Sandra Verelst has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €223,383 and a net result of €122,081. Its solvency ranks better than 74% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Dr. Sandra VerelstActiveChecked score 98/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€270,073total assets 2025
Equity
€223,383
Profit
€122,081
Turnover not published (micro format)
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
  • VERELST Sandra Julia JosephusDirector
2025 accounts 45 days early
Why 98lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 5.62, cash €233,009Equity €223,383 (82.7% of total assets)Size: total assets €270,073Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 84% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100+4
equity 82.7% of total assets
Liquidity 95+7
short-term debt 17.3% · cash 86.3%
Profitability 100=
return on assets 45.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.4%▲ +0.1 percentage points vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025highest value 05-2025: < 0.1%▼ -0.4 percentage points vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €21,000 on 30-day terms is acceptable
Liquidity ample (current ratio 5.62, compared with 3.41 in 2024, above the usual 1.5; short-term debt: 17.3% and cash: 86.3% of total assets), and 17.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 83% on liquidity, 80% on profitability and 92% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 5.62, cash €233,009
NBB · annual accounts
lowers risk · Equity €223,383 (82.7% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €270,073
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 16-03-2026, 45 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
45 days early
2024
23 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 34 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end27-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Equity above €200,000equity €223,383 ▲121%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Equity rose in 2025from €101,302 to €223,383 ▲ 121% View
  • One director decidessole director in office 1 View
  • Total assets 20252 financial years filed €270,073 View

By topic

Financials

Financial year
2025
Total assets
€270,073
Profit
€122,081
Solvency
82.7%
Total assets▲ 90.3%
Net result
20242025
Go to Financials

Timeline

Events
4
Since
2023
Next accounts
by 30-04-2027
  1. 27-07-2023Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
25-07-2023
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Dr. Sandra Verelst

What is the company number of Dr. Sandra Verelst?
0804.259.068. In Belgium the VAT number is the company number with BE in front: BE 0804.259.068.
Where is Dr. Sandra Verelst based?
The registered office is at Molenstraat 156, 2560 Nijlen.Company details
What does Dr. Sandra Verelst do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Sandra Verelst?
Private limited company (BV).
When was Dr. Sandra Verelst founded?
On 25-07-2023.
Is Dr. Sandra Verelst still active?
Yes, Dr. Sandra Verelst is an active enterprise in the KBO register.
What is the turnover of Dr. Sandra Verelst?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. Sandra Verelst profitable?
In financial year 2025, Dr. Sandra Verelst made a profit of €122,081.
Where can I find the annual accounts of Dr. Sandra Verelst?
Dr. Sandra Verelst filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sandra Verelst due?
By 30-04-2027, for financial year 2026.Timeline

Companies related to Dr. Sandra Verelst

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure